Researchers recovered 147 clinical Acinetobacter isolates from hospitalized patients at a tertiary care facility during a study period spanning May 2025 to May 2026.
The findings highlight a high burden of extended-spectrum beta-lactamase production and multidrug resistance across both common and opportunistic species. Standard hospital lab tests identified the isolates from 7,640 total clinical specimens processed for suspected bacterial infections.
Acinetobacter baumannii complex made up 88.4% of the total cohort, representing 130 isolates. Acinetobacter lwoffii accounted for 8.8% with 13 isolates, while Acinetobacter junii represented 2.0% with three isolates, and Acinetobacter haemolyticus comprised 0.7% with a single isolate.
High ESBL Rates Found
Phenotypic screening via the double-disc synergy test revealed an overall extended-spectrum beta-lactamase positivity rate of 94.6% across the 147 isolates. The data showed 96.9% positivity in the A. baumannii complex and 92.3% in A. lwoffii.
Multidrug resistance appeared in 95.2% of the tested samples. 77.6% of the isolates showed resistance to six or more distinct antimicrobial categories.
| Acinetobacter Species | Total Isolates | ESBL Positive | Multidrug Resistant |
|---|---|---|---|
| Acinetobacter baumannii complex | 130 | 126 (96.9%) | 126 (96.9%) |
| Acinetobacter lwoffii | 13 | 12 (92.3%) | 13 (100.0%) |
| Acinetobacter junii | 3 | 0 (0.0%) | 0 (0.0%) |
| Acinetobacter haemolyticus | 1 | 1 (100.0%) | 1 (100.0%) |
Beta-Lactamase Inhibitors Fail
Laboratory tests evaluating beta-lactamase inhibitor combinations demonstrated profound inefficacy in restoring antimicrobial susceptibility. Ceftazidime resistance alone stood at 92.5%, and adding clavulanic acid yielded an identical 92.5% resistance rate with zero net restoration.
Piperacillin combined with tazobactam showed 89.1% resistance compared to 68.7% for piperacillin alone. Non-baumannii species such as A. lwoffii exhibited 100.0% multidrug resistance and high cephalosporin failure.
Common Questions on Acinetobacter Resistance
What percentage of Acinetobacter isolates showed multidrug resistance?
Multidrug resistance was documented in 95.2% of the 147 clinical isolates evaluated during the study period.
Which Acinetobacter species was most frequently isolated?
Acinetobacter baumannii complex dominated the cohort at 88.4%, accounting for 130 of the 147 total isolates.
Did beta-lactamase inhibitors successfully restore drug susceptibility?
No, conventional beta-lactamase inhibitors failed to restore activity, with ceftazidime and clavulanic acid yielding a 92.5% resistance rate.
Worth a look
- Heart Transplant Eight Years Ago Lets Alan Crawford Walk 10,000 Steps Daily
- Human Concept Neurons Reactivate Content, Not Sequence, During Sleep
- Trump Vows to Work With Democrats to Cap Credit Card Rates at 10% (archyworldys.com)
- Real Rates, Not Inflation Bets, Drove the 10-Year Yield to a 2002 High (daybreakwire.com)